| Literature DB >> 31694758 |
Lin Zhu1, Ting Gao2, Weihong Yang2, Yaoning Liu2, Xuan Liu2, Yong Hu2, Yanwen Jin2, Ping Li2, Ke Xu3, Gang Zou4, Lei Zhao5, Ruiyuan Cao5, Wu Zhong5, Xianzhu Xia6, Cheng Cao7.
Abstract
Ebola virus (EBOV) is a zoonotic pathogen, the infection often results in severe, potentially fatal, systematic disease in human and nonhuman primates. VP35, an essential viral RNA-dependent RNA polymerase cofactor, is indispensable for Ebola viral replication and host innate immune escape. In this study, VP35 was demonstrated to be phosphorylated at Serine/Threonine by immunoblotting, and the major phosphorylation sites was S187, S205, T206, S208 and S317 as revealed by LC-MS/MS. By an EBOV minigenomic system, EBOV minigenome replication was shown to be significantly inhibited by the phosphorylation-defective mutant, VP35 S187A, but was potentiated by the phosphorylation mimic mutant VP35 S187D. Together, our findings demonstrate that EBOV VP35 is phosphorylated on multiple residues in host cells, especially on S187, which may contribute to efficient viral genomic replication and viral proliferation.Entities:
Keywords: EBOV replication; Minigenome; Phosphorylation; S187; VP35
Mesh:
Substances:
Year: 2019 PMID: 31694758 DOI: 10.1016/j.bbrc.2019.10.147
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575